Treatment

Cisplatin/Carboplatin; 5FU clinical trials

1 indexed studies · 0 currently recruiting

Active not recruitingPHASE2
Evorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-04)
This study looks at a new drug, evorpacept, combined with pembrolizumab and chemotherapy for advanced head and neck cancer. It aims to see if this new combination is effective for patients who haven't had treatment for their advanced disease.
For: Head and Neck Cancer · Head and Neck Squamous Cell Carcinoma
United States · Australia · Belgium